China Sees Explosion Of R&D Outsourcing Business In Three Years
This article was originally published in PharmAsia News
Executive Summary
In the three years since China began offering drug discovery and development services to foreign drug makers, the industry has become a world leader offering a wide range of services. The contract research industry in China was built in part by attracting skilled scientists and managers from Japan, the United States and other countries. A similar industry is expanding in India. China and India are taking advantage of a perceived need by Western drug makers to trim the average $1 billion cost of bringing new drugs to market. (Click here for more